Targeting TRAF6 to Improve Chemotherapy for Gastric Cancer
Author Information
Author(s): Chen Shitong, Zhang Dong, Du Yi, Shi Junbo, Gu Sikuan, Zhou Xujun, Yu Huijuan, Wang Feng, Chen Jinfei, Cui Hongjuan
Primary Institution: Southwest University, Chongqing, China
Hypothesis
The study investigates the role of TRAF6 in 5-Fluorouracil (5-FU) resistant gastric cancer and its potential as a therapeutic target.
Conclusion
The TRAF6/IRF3 axis decreases gastric cancer cell sensitivity to 5-FU, suggesting that targeting TRAF6 may help overcome chemoresistance.
Supporting Evidence
- TRAF6 is overexpressed in 5-FU-resistant gastric cancer cells.
- Knockdown of TRAF6 enhances sensitivity to 5-FU in gastric cancer cells.
- TRAF6 promotes nuclear translocation of NF-κB-p65, which is linked to chemoresistance.
Takeaway
This study found that a protein called TRAF6 makes it harder for gastric cancer cells to be treated with a common drug, 5-FU. By blocking TRAF6, we might help the drug work better.
Methodology
The study utilized short hairpin RNA (shRNA) to suppress TRAF6 expression in 5-FU resistant gastric cancer cells, and assessed cell proliferation and tumor growth in both in vivo and in vitro models.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website